This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: peripheral vascular disease

June 2014 Br J Cardiol 2014;21:51

Correspondence: is it time for a re-assessment of EECP in the UK?

Robin Roberts

Abstract

Is it time for a re-assessment of EECP in the UK? Dear Sirs, External enhanced counter pulsation (EECP) is a validated, safe, non-invasive treatment for angina and heart failure.  To date, more than 300,000 people worldwide have been treated, with 15,000 involved in clinical trials. The 2013 European Society of Cardiology (ESC) Guidelines on the Management of Stable Coronary Artery Disease1 give EECP a level 2a recommendation, meaning that the treatment should be considered for patients with refractory angina. The recommendation was made following a review of published data on the mechanisms of action and clinical benefits of EECP. The ESC c

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now